Giuseppe Vecchi, MD

Original Contribution

Comparison of Multiple Drug-Eluting Stent Percutaneous
Coronary Intervention and Surgical Revascularization in Patients
with M

08/01/2008

Matteo Aquilina , MD;

Elisabetta Varani , MD;

Marco Balducelli , MD;

Giuseppe Vecchi , MD;

Aleardo Maresta , MD;

Since the introduction of drug-eluting stents (DES) in clinical practice, it has become clear that percutaneous revascularization of multivessel coronary artery disease (CAD) could be more effective in terms of event reduction (major adverse...

Since the introduction of drug-eluting stents (DES) in clinical practice, it has become clear that percutaneous revascularization of multivessel coronary artery disease (CAD) could be more effective in terms of event reduction (major adverse...

Since the introduction of...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Administration of Eptifibatide during Transfer for Primary PCI in Patients with STEMI: Effect on Pre-PCI TIMI (full title below)

03/10/2009

Matteo Aquilina , MD;

Elisabetta Varani , MD;

Marco Balducelli , MD;

Giuseppe Vecchi , MD;

Valeria Frassineti , MSc;

Aleardo Maresta , MD;

From the Department of Cardiology, S. Maria delle Croci Hospital, Ravenna, Italy. The authors report no conflicts of interest regarding the content herein. Manuscript submitted August 7, 2008, provisional acceptance given December 2, 2008,...

From the Department of Cardiology, S. Maria delle Croci Hospital, Ravenna, Italy. The authors report no conflicts of interest regarding the content herein. Manuscript submitted August 7, 2008, provisional acceptance given December 2, 2008,...

From the Department of...

03/10/2009

Journal of Invasive Cardiology

Featured CME Course

Targeted Therapies for the Management of Chronic Lymphocytic Leukemia: Evaluating the Evidence to Optimize Patient Care and Outcomes

Upcoming Events

February 2 ⁠–⁠ February 5

February 7 ⁠–⁠ February 9

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

March 22 ⁠–⁠ March 23

NP Institute

March 27 ⁠–⁠ March 30

March 31 ⁠–⁠ April 2

April 21 ⁠–⁠ April 24

April 30 ⁠–⁠ May 4

WoundCon

May 1 ⁠–⁠ May 3

See Full Calendar